Paul Tudor Jones's BBNX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 259,632 shares of Beta Bionics, Inc. (BBNX) worth $7.91 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in BBNX, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 221,039 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +221,039 | Add 572.74% | 259,632 | $30.47 |
| Q3 2025 | +38,593 | New Buy | 38,593 | $19.87 |
Paul Tudor Jones's Beta Bionics Investment FAQs
Paul Tudor Jones first purchased Beta Bionics, Inc. (BBNX) in Q3 2025, acquiring 38,593 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Beta Bionics, Inc. (BBNX) for 2 quarters since Q3 2025.
Paul Tudor Jones's largest addition to Beta Bionics, Inc. (BBNX) was in Q4 2025, adding 259,632 shares worth $7.91 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 259,632 shares of Beta Bionics, Inc. (BBNX), valued at approximately $7.91 M.
As of the Q4 2025 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Beta Bionics, Inc. (BBNX) was 259,632 shares, as reported at the end of Q4 2025.